🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

46 results for “Sarepta Therapeutics” Clear

  1. SRP-5051

    Sarepta Therapeutics

    Muscular Dystrophy, Duchenne

    phase 2 small molecule terminated

    2 trials

  2. SRP-9003

    Sarepta Therapeutics

    Limb-Girdle Muscular Dystrophy, Type 2E

    phase 2 gene therapy terminated

    1 trial

  3. SRP-9004

    Sarepta Therapeutics

    Limb-Girdle Muscular Dystrophy, Type 2D

    phase 2 gene therapy completed

    1 trial

  4. VESLETEPLIRSEN(SRP-5051)

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    phase 2 small molecule active

    1 trial

  5. Vesleteplirsen

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    phase 2 small molecule terminated

    1 trial

  6. delandistrogene moxeparvovec

    Sarepta Therapeutics

    Muscular Dystrophy, Duchenne

    phase 2 gene therapy active

    2 trials

  7. AVI-4020 Injection

    Sarepta Therapeutics

    West Nile Virus

    phase 1 small molecule completed

    1 trial

  8. AVI-4020 Injection

    Sarepta Therapeutics

    West Nile Fever

    phase 1 small molecule terminated

    1 trial

  9. AVI-4065 Injection

    Sarepta Therapeutics

    Encephalitis

    phase 1 small molecule completed

    1 trial

  10. AVI-4126 Injection (RESTEN-NG®)

    Sarepta Therapeutics

    Neoplasms

    phase 1 small molecule completed

    1 trial

  11. AVI-6003

    Sarepta Therapeutics

    Marburg Hemorrhagic Fever

    phase 1 small molecule completed

    1 trial

  12. AVI-7100

    Sarepta Therapeutics

    Influenza

    phase 1 small molecule terminated

    1 trial

  13. AVI-7288

    Sarepta Therapeutics

    Marburg Hemorrhagic Fever

    phase 1 small molecule completed

    1 trial

  14. AVI-7537

    Sarepta Therapeutics

    Ebola Hemorrhagic Fever

    phase 1 small molecule terminated

    1 trial

  15. Idefirix 11 mg powder for concentrate for solution for infusion, Delandistrogene moxeparvovec-rokl

    Sarepta Therapeutics

    Duchenne muscular dystrophy (DMD)

    phase 1 small molecule active

    1 trial

  16. Placebo

    Sarepta Therapeutics

    Ebola Hemorrhagic Fever

    phase 1 small molecule completed

    1 trial

  17. SRP-1005

    Sarepta Therapeutics

    Huntington's Disease

    phase 1 small molecule active

    1 trial

  18. SRP-6004

    Sarepta Therapeutics

    Limb Girdle Muscular Dystrophy

    phase 1 gene therapy terminated

    1 trial

  19. SRP-9004

    Sarepta Therapeutics

    Limb Girdle Muscular Dystrophy

    phase 1 small molecule terminated

    1 trial

  20. rAAVrh74.MHCK7.DYSF.DV

    Sarepta Therapeutics

    Dysferlinopathy

    phase 1 small molecule completed

    1 trial

  21. ELEVIDYS

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    approved small molecule active

    1 trial

  22. Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    approved small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources